Table 3.
Prevalence and concentrations of detected mycotoxins found in the urine of the 172 participants of this study, along with the limit of detection (LOD) and quantification (LOQ) of the method.
| Mycotoxin | LOD (ng/mL) |
LOQ (ng/mL) |
Over LOQ (%) |
Prevalence (%) |
Mean (SD) (ng/mL) |
Mean (SD) ng/mg Creat a |
Median (IQ Range) (ng/mL) |
|---|---|---|---|---|---|---|---|
| AFB1 | 0.08 | 0.1 | 7 | 8 | 0.3 (0.3) | 0.3 (0.2) | 0.3 (0.1–0.3) |
| AFM1 | 0.8 | 1.1 | 1 | 1 | 1.8 (1.0) | 4.3 (2.8) | 1.8 (1.5–2.2) |
| OTA | 0.4 | 2.1 | 0 | 0.6 | - | - | - |
| DON | 6.6 | 20.1 | 63 | 73 | 60.7 (78.7) | 64.6 (205.8) | 37.6 (23.2–61.1) |
| ZEN | 0.5 | 1.7 | 0 | 0.6 | - | - | - |
| α-ZEL | 1.2 | 3.7 | 6 | 8 | 41.8 (115.5) | 19.1 (25.2) | 11.8 (6.2–16.5) |
| β-ZEL | 0.7 | 2.3 | 7.5 | 7.5 | 17.4 (16.1) | 21.9 (57.8) | 8.6 (6.9–31.3) |
a ng/mg creatinine-adjusted; IQ range: interquantile range; SD: standard deviation.